José L Labandeira-García Selected Research

Proto-Oncogene Mas

1/2020

SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José L Labandeira-García Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 05/2021 - 03/2013
2	Dyskinesias (Dyskinesia) 05/2017 - 12/2015
2	Parkinsonian Disorders (Parkinsonism) 09/2015 - 03/2013
1	Fever (Fevers) 01/2020
1	Infections 01/2020
1	Inflammation (Inflammations) 01/2020
1	Cytokine Release Syndrome 01/2020
1	COVID-19 01/2020
1	Obesity 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Dementia (Dementias) 01/2018
1	Brain Diseases (Brain Disorder) 05/2017

Drug/Important Bio-Agent (IBA)

3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2017 - 03/2013
1	Glucosylceramidase (Glucocerebrosidase)IBA 05/2021
1	alamandineIBA 01/2020
1	CytokinesIBA 01/2020
1	angiotensin I (1-7)IBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Proto-Oncogene MasIBA 01/2020
1	Angiotensin IIIBA 01/2020
1	Nicotine FDA Link 01/2019
1	alpha-SynucleinIBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 05/2017
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 12/2015
1	Dopamine D3 ReceptorsIBA 12/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2015

Therapy/Procedure

1	Therapeutics 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2013
1	Transplantation 03/2013